Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger protein 19B pseudogene X-linked (RNF19BPX, also known as RNF19BX) is a human pseudogene, meaning it is a DNA sequence similar to a functional gene (in this case, likely the RNF19B gene) but is non-functional due to mutations preventing protein coding[1][3][5][7]. Pseudogenes may sometimes be transcribed into non-coding RNAs, and in some cases, these RNAs can have regulatory effects on their parental genes, e.g., acting as decoys or producing small interfering RNAs, but there is no evidence that RNF19BPX encodes a functional protein or is a therapeutic target[2][4]. No direct information links RNF19BPX to disease, drug interactions, or clinical biomarkers. As a pseudogene, RNF19BPX does not belong to any classical targetable molecular family (such as enzyme, receptor, transporter) and is not considered a valid drug target or biomarker at this time[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 19B pseudogene X-linked (RNF19BPX).